Evidence map›Paper›PMID 38665815›Full record

ArticleFrontiers in bioengineering and biotechnology2024

New strontium-based coatings show activity against pathogenic bacteria in spine infection.

Daniele Ghezzi, Gabriela Graziani, Martina Cappelletti, Inna V Fadeeva, Matteo Montesissa, Enrico Sassoni, Giorgia Borciani, Katia Barbaro, Marco Boi, Nicola Baldini and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Daniele Ghezzi *University of Bologna, Department of Pharmacy and Biotechnology, Bologna, Italy.
Gabriela Graziani *IRCCS Istituto Ortopedico Rizzoli, Biomedical Science and Technologies and Nanobiotechnology Lab, Bologna, Italy.
Martina CappellettiUniversity of Bologna, Department of Pharmacy and Biotechnology, Bologna, Italy.
Inna V FadeevaAA Baikov Institute of Metallurgy and Materials Science, Russian Academy of Sciences, Moscow, Russia.
Matteo MontesissaUniversity of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, Italy.
Enrico SassoniUniversity of Bologna, Department of Civil, Chemical, Environmental and Materials Engineering, Bologna, Italy.
Giorgia BorcianiIRCCS Istituto Ortopedico Rizzoli, Biomedical Science and Technologies and Nanobiotechnology Lab, Bologna, Italy.
Katia BarbaroIstituto Zooprofilattico, Rome, Italy.
Marco BoiIRCCS Istituto Ortopedico Rizzoli, Biomedical Science and Technologies and Nanobiotechnology Lab, Bologna, Italy.
Nicola BaldiniIRCCS Istituto Ortopedico Rizzoli, Biomedical Science and Technologies and Nanobiotechnology Lab, Bologna, Italy.
Julietta V RauIstituto di Struttura della Materia, Consiglio Nazionale delle Ricerche (ISM-CNR), Rome, Italy.
University of Bologna · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITBaikov Institute of Metallurgy and Materials Science · RUInstitute of Structure of Matter · ITIstituto Ortopedico Rizzoli · ITIstituto Zooprofilattico Sperimentale della Sardegna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections of implants and prostheses represent relevant complications associated with the implantation of biomedical devices in spine surgery. Indeed, due to the length of the surgical procedures and the need to implant invasive devices, infections have high incidence, interfere with osseointegration, and are becoming increasingly difficult to threat with common therapies due to the acquisition of antibiotic resistance genes by pathogenic bacteria. The application of metal-substituted tricalcium phosphate coatings onto the biomedical devices is a promising strategy to simultaneously prevent bacterial infections and promote osseointegration/osseoinduction. Strontium-substituted tricalcium phosphate (Sr-TCP) is known to be an encouraging formulation with osseoinductive properties, but its antimicrobial potential is still unexplored. To this end, novel Sr-TCP coatings were manufactured by Ionized Jet Deposition technology and characterized for their physiochemical and morphological properties, cytotoxicity, and bioactivity against

Indexed as

antibacterial coatingsbacterial adhesioninfectionorthopaedicsspinestrontium tricalcium phosphate

Identifiers

PMID38665815
PMCPMC11044685
OpenAlexW4394687664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.